XML 21 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss, Net of Taxes
Retained Earnings
Balance, beginning of period (in shares) at Oct. 31, 2021   67,300,000      
Balance, beginning of period at Oct. 31, 2021   $ 0.7 $ 750.9 $ (22.5) $ 880.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued under employee stock purchase and share-based compensation plans (in shares)   500,000      
Stock issued (taxes withheld) under employee stock purchase and share-based compensation plans, net   $ 0.0 (8.1)    
Repurchase of common stock (in shares)   (1,000,000.0)      
Share-based compensation expense     16.8    
Repurchase of common stock   $ 0.0 (43.3)    
Other comprehensive income (loss)       (2.6)  
Net income $ 124.8       124.8
Dividends          
Common stock ($0.220 and $0.195 per share)         (26.2)
Stock issued under share-based compensation plans         (1.1)
Balance, end of period (in shares) at Apr. 30, 2022   66,800,000      
Balance, end of period at Apr. 30, 2022 1,669.6 $ 0.7 716.4 (25.2) 977.7
Balance, beginning of period (in shares) at Jan. 31, 2022   67,400,000      
Balance, beginning of period at Jan. 31, 2022   $ 0.7 737.0 (24.6) 942.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued under employee stock purchase and share-based compensation plans (in shares)   0      
Stock issued (taxes withheld) under employee stock purchase and share-based compensation plans, net   $ 0.0 1.0    
Repurchase of common stock (in shares)   (700,000)      
Share-based compensation expense     8.4    
Repurchase of common stock   $ 0.0 (30.0)    
Other comprehensive income (loss)       (0.6)  
Net income 48.8       48.8
Dividends          
Common stock ($0.220 and $0.195 per share)         (13.0)
Stock issued under share-based compensation plans         (0.2)
Balance, end of period (in shares) at Apr. 30, 2022   66,800,000      
Balance, end of period at Apr. 30, 2022 1,669.6 $ 0.7 716.4 (25.2) 977.7
Balance, beginning of period (in shares) at Oct. 31, 2022   65,600,000      
Balance, beginning of period at Oct. 31, 2022 $ 1,717.2 $ 0.7 675.5 (16.2) 1,057.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued under employee stock purchase and share-based compensation plans (in shares)   600,000      
Stock issued (taxes withheld) under employee stock purchase and share-based compensation plans, net   $ 0.0 (10.9)    
Repurchase of common stock (in shares) 0 0      
Share-based compensation expense     14.6    
Repurchase of common stock   $ 0.0 0.0    
Other comprehensive income (loss)       1.6  
Net income $ 90.4       90.4
Dividends          
Common stock ($0.220 and $0.195 per share)         (29.0)
Stock issued under share-based compensation plans         (1.1)
Balance, end of period (in shares) at Apr. 30, 2023   66,100,000      
Balance, end of period at Apr. 30, 2023 $ 1,782.8 $ 0.7 679.2 (14.6) 1,117.5
Balance, beginning of period (in shares) at Jan. 31, 2023   66,100,000      
Balance, beginning of period at Jan. 31, 2023   $ 0.7 670.7 (15.1) 1,080.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued under employee stock purchase and share-based compensation plans (in shares)   0      
Stock issued (taxes withheld) under employee stock purchase and share-based compensation plans, net   $ 0.0 0.8    
Repurchase of common stock (in shares) 0 0      
Share-based compensation expense     7.7    
Repurchase of common stock   $ 0.0 0.0    
Other comprehensive income (loss)       0.5  
Net income $ 51.9       51.9
Dividends          
Common stock ($0.220 and $0.195 per share)         (14.5)
Stock issued under share-based compensation plans         (0.2)
Balance, end of period (in shares) at Apr. 30, 2023   66,100,000      
Balance, end of period at Apr. 30, 2023 $ 1,782.8 $ 0.7 $ 679.2 $ (14.6) $ 1,117.5